Tari Leslie

CHIEF SCIENTIFIC OFFICERCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Mar 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$39K
Net Open-Market Flow
-$39K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2025Sell(S)2K$21.96$39K16K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610618-25-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly: